BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21237568)

  • 1. Effect of ketamine on endogenous pain modulation in healthy volunteers.
    Niesters M; Dahan A; Swartjes M; Noppers I; Fillingim RB; Aarts L; Sarton EY
    Pain; 2011 Mar; 152(3):656-663. PubMed ID: 21237568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.
    Pöyhiä R; Vainio A
    Clin J Pain; 2006 Jan; 22(1):32-6. PubMed ID: 16340591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive transcranial magnetic stimulation induced analgesia depends on N-methyl-D-aspartate glutamate receptors.
    Ciampi de Andrade D; Mhalla A; Adam F; Texeira MJ; Bouhassira D
    Pain; 2014 Mar; 155(3):598-605. PubMed ID: 24342462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the noradrenergic and serotonergic contributions of diffuse noxious inhibitory controls in a monoiodoacetate model of osteoarthritis.
    Lockwood SM; Bannister K; Dickenson AH
    J Neurophysiol; 2019 Jan; 121(1):96-104. PubMed ID: 30461363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
    Felsby S; Nielsen J; Arendt-Nielsen L; Jensen TS
    Pain; 1996 Feb; 64(2):283-291. PubMed ID: 8740606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
    Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
    Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients.
    Cohen SP; Verdolin MH; Chang AS; Kurihara C; Morlando BJ; Mao J
    J Pain; 2006 Jun; 7(6):391-8. PubMed ID: 16750795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of motor cortex modulation and descending inhibitory systems on pain thresholds in healthy subjects.
    Reidler JS; Mendonca ME; Santana MB; Wang X; Lenkinski R; Motta AF; Marchand S; Latif L; Fregni F
    J Pain; 2012 May; 13(5):450-8. PubMed ID: 22515945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Offset analgesia in neuropathic pain patients and effect of treatment with morphine and ketamine.
    Niesters M; Hoitsma E; Sarton E; Aarts L; Dahan A
    Anesthesiology; 2011 Nov; 115(5):1063-71. PubMed ID: 21878810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers.
    Niesters M; Khalili-Mahani N; Martini C; Aarts L; van Gerven J; van Buchem MA; Dahan A; Rombouts S
    Anesthesiology; 2012 Oct; 117(4):868-77. PubMed ID: 22890117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.
    Hughes AM; Rhodes J; Fisher G; Sellers M; Growcott JW
    Br J Clin Pharmacol; 2002 Jun; 53(6):604-12. PubMed ID: 12047485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.
    Sigtermans M; Noppers I; Sarton E; Bauer M; Mooren R; Olofsen E; Dahan A
    Eur J Pain; 2010 Mar; 14(3):302-7. PubMed ID: 19540140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans.
    Guirimand F; Dupont X; Brasseur L; Chauvin M; Bouhassira D
    Anesth Analg; 2000 Feb; 90(2):408-14. PubMed ID: 10648330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nucleus raphe magnus OFF-cells are involved in diffuse noxious inhibitory controls.
    Chebbi R; Boyer N; Monconduit L; Artola A; Luccarini P; Dallel R
    Exp Neurol; 2014 Jun; 256():39-45. PubMed ID: 24681000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control.
    Wong CS; Liaw WJ; Tung CS; Su YF; Ho ST
    Reg Anesth; 1996; 21(6):534-41. PubMed ID: 8956390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-ketamine modulates hyperalgesia in patients with chronic pancreatitis pain.
    Bouwense SA; Buscher HC; van Goor H; Wilder-Smith OH
    Reg Anesth Pain Med; 2011; 36(3):303-7. PubMed ID: 21490522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam.
    Kunz M; Scholl KE; Schu U; Lautenbacher S
    Exp Brain Res; 2006 Nov; 175(2):363-71. PubMed ID: 16816943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
    Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
    Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
    Jørum E; Warncke T; Stubhaug A
    Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.